Goldman Sachs’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-523,630
| Closed | -$3.06M | – | 5415 |
|
2022
Q4 | $3.06M | Buy |
523,630
+189,551
| +57% | +$1.11M | ﹤0.01% | 2986 |
|
2022
Q3 | $2.24M | Buy |
334,079
+146,591
| +78% | +$982K | ﹤0.01% | 3285 |
|
2022
Q2 | $789K | Buy |
+187,488
| New | +$789K | ﹤0.01% | 4108 |
|
2021
Q4 | – | Sell |
-15,773
| Closed | -$52K | – | 5759 |
|
2021
Q3 | $52K | Sell |
15,773
-78,499
| -83% | -$259K | ﹤0.01% | 5185 |
|
2021
Q2 | $398K | Buy |
94,272
+25,687
| +37% | +$108K | ﹤0.01% | 4550 |
|
2021
Q1 | $342K | Sell |
68,585
-69,543
| -50% | -$347K | ﹤0.01% | 4564 |
|
2020
Q4 | $1.75M | Buy |
138,128
+116,847
| +549% | +$1.48M | ﹤0.01% | 3142 |
|
2020
Q3 | $209K | Buy |
21,281
+2,237
| +12% | +$22K | ﹤0.01% | 4043 |
|
2020
Q2 | $189K | Sell |
19,044
-22,566
| -54% | -$224K | ﹤0.01% | 4002 |
|
2020
Q1 | $368K | Sell |
41,610
-7,920
| -16% | -$70K | ﹤0.01% | 3641 |
|
2019
Q4 | $457K | Buy |
49,530
+10,073
| +26% | +$92.9K | ﹤0.01% | 3695 |
|
2019
Q3 | $232K | Buy |
39,457
+13,144
| +50% | +$77.3K | ﹤0.01% | 3869 |
|
2019
Q2 | $316K | Sell |
26,313
-16,757
| -39% | -$201K | ﹤0.01% | 3702 |
|
2019
Q1 | $520K | Buy |
43,070
+28,404
| +194% | +$343K | ﹤0.01% | 3551 |
|
2018
Q4 | $184K | Sell |
14,666
-104,148
| -88% | -$1.31M | ﹤0.01% | 3758 |
|
2018
Q3 | $1.76M | Sell |
118,814
-6,681
| -5% | -$99.1K | ﹤0.01% | 2941 |
|
2018
Q2 | $2.11M | Buy |
125,495
+34,293
| +38% | +$577K | ﹤0.01% | 2865 |
|
2018
Q1 | $2.09M | Sell |
91,202
-7,584
| -8% | -$174K | ﹤0.01% | 2860 |
|
2017
Q4 | $2.56M | Buy |
98,786
+65,086
| +193% | +$1.68M | ﹤0.01% | 2695 |
|
2017
Q3 | $497K | Buy |
33,700
+16,795
| +99% | +$248K | ﹤0.01% | 3508 |
|
2017
Q2 | $236K | Sell |
16,905
-15,444
| -48% | -$216K | ﹤0.01% | 3910 |
|
2017
Q1 | $552K | Buy |
32,349
+19,046
| +143% | +$325K | ﹤0.01% | 3457 |
|
2016
Q4 | $137K | Sell |
13,303
-3,601
| -21% | -$37.1K | ﹤0.01% | 4014 |
|
2016
Q3 | $171K | Buy |
16,904
+4,470
| +36% | +$45.2K | ﹤0.01% | 3995 |
|
2016
Q2 | $140K | Buy |
+12,434
| New | +$140K | ﹤0.01% | 4007 |
|
2015
Q4 | – | Sell |
-11,679
| Closed | -$219K | – | 4656 |
|
2015
Q3 | $219K | Sell |
11,679
-15,277
| -57% | -$286K | ﹤0.01% | 3816 |
|
2015
Q2 | $401K | Buy |
26,956
+1,832
| +7% | +$27.3K | ﹤0.01% | 3502 |
|
2015
Q1 | $381K | Buy |
25,124
+5,613
| +29% | +$85.1K | ﹤0.01% | 3486 |
|
2014
Q4 | $260K | Sell |
19,511
-35,120
| -64% | -$468K | ﹤0.01% | 3801 |
|
2014
Q3 | $689K | Sell |
54,631
-2,714
| -5% | -$34.2K | ﹤0.01% | 3137 |
|
2014
Q2 | $579K | Sell |
57,345
-9,800
| -15% | -$98.9K | ﹤0.01% | 3264 |
|
2014
Q1 | $903K | Buy |
+67,145
| New | +$903K | ﹤0.01% | 3052 |
|